Astra's Farxiga Meets Primary Endpoint For Heart Failure Treatment
(Alliance News) - FTSE 100-listed AstraZeneca PLC on Tuesday reported positive results from the third phase of DAPA-HF trial.The drugmaker said the study showed Farxiga met the primary with Read More